Dream DisorderNCT05872594
Prevalence of a Phenomenon of Epic Dream Disorder
An observational study of Dream Disorder, run by I.M. Sechenov First Moscow State Medical University at 1 site in Russia.
Trial summary
A single-center, cross-sectional, non-interventional study based on the sleep department of the Kozhevnikov Clinic for Nervous Diseases at Sechenov University. A.Y. Kozhevnikov Sechenov University is being conducted between September 2022 and December 2023 to assess the prevalence and associated symptoms and risk… Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Dream Disorder
- What is being tested?
- Online questionnaire
- How many people
- 1,000 participants
- Where
- 1 siteRussia
- Study dates
- 30 Sep 2022to 30 Mar 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Conditionally healthy individuals expressing their interest to participate by clicking the link to the questionnaires and informed consent form that will be spreaded in social media, student communities, and university departmental staff communities
Who may be able to join
- consent to participate in the study, expressed by ticking the appropriate box on the website after reading the text of the informed consent, confirming their understanding of the study and their consent to participate in it;
Who cannot join
- age < 18 years; This criterion is evaluated when completing the questionnaire, questionnaires from participants under 18 years old will not be included in the statistical analysis
Trial locations and contacts
1 site in 1 country.
Mikhail Rumyantsev contact
Russia1 site, 1 recruiting
- Recruiting
II.M. Sechenov First Moscow State Medical University (Sechenov University)
Moscow
Mikhail Poluektov, PhD
Polina Pchelina, PhD
About this study
Official title: Assessing the Prevalence and Associated Risk Factors of a Phenomenon of Epic Dream Disorder: a Cross-sectional Study
A single-center, cross-sectional, non-interventional study based on the sleep department of the Kozhevnikov Clinic for Nervous Diseases at Sechenov University. A.Y. Kozhevnikov Sechenov University is being conducted between September 2022 and December 2023 to assess the prevalence and associated symptoms and risk factors of a multiple dreams with vivid emotion, causing morning and daytime symptoms - phenomenon of Epic Dream Disorder (EDD). Demographic, sleep and psychological characteristics of people with multiple dreams will be identified, including the following standardized scales: Spielberger Anxiety Scale, Beck Depression Scale, Shortened Sleep Questionnaire. Data will be collected by mean of online questionnaire tool. According to the data obtained, prevalence of the phenomenon, differences between continuous, rank and categorical variables will be calculated in participants with and without EDD. Multivariate logistic regression will be performed to assess associated risk factors of EDD.
Read the detailed description
In clinical practice, there are patients complaining for numerous dreams, which negatively affect the daytime well-being of patients, although these complaints do not fall into the category of nightmares. There are currently no data on the prevalence of the phenomenon of this phenomenon. Studies conducted on small groups of patients have found that they are more likely to have chronic pain syndrome, family history of their complaints.
The proposed study will be able to provide the first data on the prevalence and concomitant symptoms of multiple dreams. This will allow the authors to give a more precise definition of this phenomenon, describe its concomitant symptoms, and evaluate the relevance of its diagnosis and treatment. The results of the study will set the stage for further clinical research on the pathogenesis and therapy approaches. The further studies are needed to explain the causes of this phenomenon to the patients and provide them with the necessary assistance.
In view of the high workload of the medical staff, and clinical centers under the COVID-19 pandemic, and in order to increase convenience for both study participants and the researchers, data for this study will be collected remotely. The implementation of the study objectives did not require a face-to-face examination of the participants. Internet-based data collection will further simplify the processing of the data. This approach to conducting the study has already shown its applicability in a number of clinical trials.
The study will be conducted at the I.M. Sechenov First Moscow State Medical University, Russian Ministry of Health, UTH No. 3, Clinic of Nervous Diseases. A.Y. Kozhevnikov, Department of Sleep Medicine.
This study plans to inсlude all participants who agreed to participate (i.e., who clicked on the button "agree" after reading informed consent form). Information about the study and link to the questionnaires and informed consent form will be spreaded in social media, student communities, and university departmental staff communities The demographic, sleep, and psychological characteristics of people with multiple dreams will be assessed. Then a statistical analysis will be performed to compare the differences in rank, continuous, and categorical variables, and perform a multivariate logistic regression.
- Conditions
- Dream Disorder
- Being tested
- Online questionnaire
- Keywords
- dream, epic dream disorder, daytime symptoms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Online questionnaireDiagnostic test
data will be collected remotely on the online platform Qualtrics
| Study group | Role | What they receive |
|---|---|---|
| study group | all participants older than 18 years who agreed to participate (i.e., who clicked on the button "agree" after reading informed consent form) with no regard to sex, race, education, family status Receives: Diagnostic Test: Online questionnaire |
What is being measured
The primary outcome is the main question the study is designed to answer.
Prevalence of the phenomenon of epic dream disorder
prevalence of the disease - the proportion of participants with the diagnosed epic dream disorder to the whole sample
Measured: Through study completion, an average of 1 year
Secondary outcomes (62)
Demographic outcomes: Sex
options (male, female)
Measured: Through study completion, an average of 1 year
Demographic outcomes: Age
Age in years
Measured: Through study completion, an average of 1 year
Demographic outcomes: Weight
Weight in kg
Measured: Through study completion, an average of 1 year
Demographic outcomes: Height
Height in cm
Measured: Through study completion, an average of 1 year
Demographic outcomes: Level of education
choose category for the level of education
Measured: Through study completion, an average of 1 year
Demographic outcomes: name the University
For students only
Measured: Through study completion, an average of 1 year
Demographic outcomes: name your department
For students only
Measured: Through study completion, an average of 1 year
Demographic outcomes: year of study
For students only
Measured: Through study completion, an average of 1 year
Demographic outcomes: Employment status
choose category for the employment status and specify your scope of activities if any
Measured: Through study completion, an average of 1 year
use of nicotine
Fact and frequency of use of nicotine
Measured: Through study completion, an average of 1 year
use of alcohol
Fact and frequency of use of alcohol
Measured: Through study completion, an average of 1 year
Medical history
Presence of any chronic illnesses (specify the name)
Measured: Through study completion, an average of 1 year
duration of complaints
Question: how long do you experience multiple dreams
Measured: Through study completion, an average of 1 year
Average duration of sleep
hours
Measured: Through study completion, an average of 1 year
dreams during daytime nap
Presence of dreams during daytime nap (yes or no)
Measured: Through study completion, an average of 1 year
Amount of dreams during the night
specify number (0, 1, 2, 3 and more)
Measured: Through study completion, an average of 1 year
discomfort after the night of active dreaming
Presence of discomfort after the night of active dreaming in the morning or during the day
Measured: Through study completion, an average of 1 year
triggers of active dreaming
Were you able to identify a factor or event that triggered the appearance of multiple dreams? If yes, specify.
Measured: Through study completion, an average of 1 year
Intensity of thought activity in dream
range 1-5
Measured: Through study completion, an average of 1 year
Intensity of speech activity in dream
range 1-5
Measured: Through study completion, an average of 1 year
Intensity of running in dream
range 1-5
Measured: Through study completion, an average of 1 year
Intensity of walking in dream
range 1-5
Measured: Through study completion, an average of 1 year
Intensity of monotonous physical movements in dream
range 1-5
Measured: Through study completion, an average of 1 year
Intensity of flight in dream
range 1-5
Measured: Through study completion, an average of 1 year
Intensity of swimming in dream
range 1-5
Measured: Through study completion, an average of 1 year
Intensity of jumping in dream
range 1-5
Measured: Through study completion, an average of 1 year
Intensity of trip by transport in dream
range 1-5
Measured: Through study completion, an average of 1 year
recalling dreams upon awakening
Question: After waking up, do you remember what you saw in the dream? with 3 options - I remember that I had a dream, but I don't remember what it was about
- I remember what the dream was about
- I remember all the details of the dream
Measured: Through study completion, an average of 1 year
characteristics of dream content
Intensity of positive emotions (range 1-5)
Measured: Through study completion, an average of 1 year
characteristics of dream content
Intensity of negative emotions (range 1-5)
Measured: Through study completion, an average of 1 year
Impression that your brain stays awake while you sleep
range 1-5
Measured: Through study completion, an average of 1 year
Any peculiarities of your dream
specify
Measured: Through study completion, an average of 1 year
Awareness of a dream
I don't realize I'm dreaming; I am aware that I am dreaming, but I have no control; Awareness of dreaming and controlling; I realize that I'm dreaming and I can change the plot
Measured: Through study completion, an average of 1 year
Subjective symptoms in the morning after a night of active dreaming
Presence and length of the symptome Having difficulty knowing whether something happened in the dream or in reality
Measured: Through study completion, an average of 1 year
Subjective symptoms in the morning after a night of active dreaming
Presence and length of the symptom the feeling you had in the dream persists during the wakefulness for more than a few seconds
Measured: Through study completion, an average of 1 year
Subjective symptoms in the morning after a night of active dreaming
Presence and length of the symptom Heart palpitations
Measured: Through study completion, an average of 1 year
Subjective symptoms in the morning after a night of active dreaming
Presence and length of the symptom Shortness of breath
Measured: Through study completion, an average of 1 year
Subjective symptoms in the morning after a night of active dreaming
Presence and length of the symptom Hyperhidrosis
Measured: Through study completion, an average of 1 year
Subjective symptoms in the morning after a night of active dreaming
Presence and length of the symptom feeling Cold
Measured: Through study completion, an average of 1 year
Subjective symptoms in the morning after a night of active dreaming
Presence and length of the symptom Fatigue
Measured: Through study completion, an average of 1 year
Subjective symptoms in the morning after a night of active dreaming
Presence and length of the symptom Bad mood
Measured: Through study completion, an average of 1 year
Subjective symptoms in the morning after a night of active dreaming
Presence and length of the symptom Muscle pain
Measured: Through study completion, an average of 1 year
Subjective symptoms in the morning after a night of active dreaming
Presence and length of the symptom Headache
Measured: Through study completion, an average of 1 year
Subjective symptoms in the morning after a night of active dreaming
Presence and length of the symptom Pain in chest
Measured: Through study completion, an average of 1 year
Subjective symptoms in the morning after a night of active dreaming
Presence and length of the symptom Balance disturbance
Measured: Through study completion, an average of 1 year
Subjective symptoms in the morning after a night of active dreaming
Presence and length of the symptom Loss of tactile sensitivity
Measured: Through study completion, an average of 1 year
Subjective symptoms in the morning after a night of active dreaming
Presence and length of the symptom Tingling/frowning sensation
Measured: Through study completion, an average of 1 year
Subjective symptoms in the morning after a night of active dreaming
Presence and length of the symptom Anxiety
Measured: Through study completion, an average of 1 year
Subjective symptoms in the morning after a night of active dreaming
Presence and length of the symptom Weakness
Measured: Through study completion, an average of 1 year
Subjective symptoms in the morning after a night of active dreaming
Presence and length of the symptom Nausea
Measured: Through study completion, an average of 1 year
Subjective symptoms in the morning after a night of active dreaming
Presence and length of the other symptoms, if any
Measured: Through study completion, an average of 1 year
Use of medications
Question about the use of medication, no or yes (specify the name)
Measured: Through study completion, an average of 1 year
Dose of medications
Question about the dose of medication, if any
Measured: Through study completion, an average of 1 year
Frequency of medications
Question about the frequency of medications use, if any
Measured: Through study completion, an average of 1 year
awakenings during the night
Number of awakenings during the night
Measured: Through study completion, an average of 1 year
Frequency of nights with multiple dreams
Number of nights per week
Measured: Through study completion, an average of 1 year
Seasonal fluctuation of the multiple dreams
During which season do the multiple dreams occur more often
Measured: Through study completion, an average of 1 year
Family history of Excessive dream disorder
Did any of your family members has the same complaints, if yes, specify
Measured: Through study completion, an average of 1 year
Depression symptoms
Beck Depression scale
Measured: Through study completion, an average of 1 year
State anxiety symptoms
State anxiety by Spielberger Anxiety Scale
Measured: Through study completion, an average of 1 year
Trait anxiety symptoms
Trait anxiety by Spielberger Anxiety Scale
Measured: Through study completion, an average of 1 year
Shortened Sleep Questionnaire
Validated questionnaire to evaluate insomniac complaints, parasomnias, use of medications, hypersomnias, sleep related breathe disorders
Measured: Through study completion, an average of 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 May 2023
- Study start30 Sep 2022
- Primary completion30 Dec 2023 (estimated)
- Study completion30 Mar 2024 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Dream DisorderStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Ecologic or community
- Time perspective
- Cross-sectional
- Enrolment
- 1,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- I.M. Sechenov First Moscow State Medical University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Polina Pchelina, I.M. Sechenov First Moscow State Medical University
- Investigators
- Mikhail Poluektov, PhD, Study director, I.M. Sechenov First Moscow State Medical University (Sechenov University)Polina Pchelina, PhD, Principal investigator, I.M. Sechenov First Moscow State Medical University (Sechenov University)
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05872594
- Sponsor's protocol ID
- 0000640001
- Status last verified
- May 2023
- First submitted
- 27 Sep 2022
- Last updated
- 24 May 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 24 May 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Assessing the Prevalence and Associated Risk Factors of a Phenomenon of Epic Dream Disorder: a Cross-sectional Study
- ClinicalTrials.gov ID
- NCT05872594
- Acronym / sponsor ID
- 0000640001
- Conditions
- Dream Disorder
- Keywords
- dream, epic dream disorder, daytime symptoms
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 1,000 participants (estimated)
- Lead sponsor
- I.M. Sechenov First Moscow State Medical UniversityUniversity, hospital or other
- Study start
- 30 Sep 2022 (actual)
- Primary completion
- 30 Dec 2023 (estimated)
- Study completion
- 30 Mar 2024 (estimated)
- First posted
- 24 May 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
A single-center, cross-sectional, non-interventional study based on the sleep department of the Kozhevnikov Clinic for Nervous Diseases at Sechenov University. A.Y. Kozhevnikov Sechenov University is being conducted between September 2022 and December 2023 to assess the prevalence and associated symptoms and risk factors of a multiple dreams with vivid emotion, causing morning and daytime symptoms - phenomenon of Epic Dream Disorder (EDD). Demographic, sleep and psychological characteristics of people with multiple dreams will be identified, including the following standardized scales: Spielberger Anxiety Scale, Beck Depression Scale, Shortened Sleep Questionnaire. Data will be collected by mean of online questionnaire tool. According to the data obtained, prevalence of the phenomenon, differences between continuous, rank and categorical variables will be calculated in participants with and without EDD. Multivariate logistic regression will be performed to assess associated risk factors of EDD.
Detailed description
In clinical practice, there are patients complaining for numerous dreams, which negatively affect the daytime well-being of patients, although these complaints do not fall into the category of nightmares. There are currently no data on the prevalence of the phenomenon of this phenomenon. Studies conducted on small groups of patients have found that they are more likely to have chronic pain syndrome, family history of their complaints.
The proposed study will be able to provide the first data on the prevalence and concomitant symptoms of multiple dreams. This will allow the authors to give a more precise definition of this phenomenon, describe its concomitant symptoms, and evaluate the relevance of its diagnosis and treatment. The results of the study will set the stage for further clinical research on the pathogenesis and therapy approaches. The further studies are needed to explain the causes of this phenomenon to the patients and provide them with the necessary assistance.
In view of the high workload of the medical staff, and clinical centers under the COVID-19 pandemic, and in order to increase convenience for both study participants and the researchers, data for this study will be collected remotely. The implementation of the study objectives did not require a face-to-face examination of the participants. Internet-based data collection will further simplify the processing of the data. This approach to conducting the study has already shown its applicability in a number of clinical trials.
The study will be conducted at the I.M. Sechenov First Moscow State Medical University, Russian Ministry of Health, UTH No. 3, Clinic of Nervous Diseases. A.Y. Kozhevnikov, Department of Sleep Medicine.
This study plans to inсlude all participants who agreed to participate (i.e., who clicked on the button "agree" after reading informed consent form). Information about the study and link to the questionnaires and informed consent form will be spreaded in social media, student communities, and university departmental staff communities The demographic, sleep, and psychological characteristics of people with multiple dreams will be assessed. Then a statistical analysis will be performed to compare the differences in rank, continuous, and categorical variables, and perform a multivariate logistic regression.
Study design
- Observational model
- Ecologic or community
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| study group | – | Diagnostic Test: Online questionnaireall participants older than 18 years who agreed to participate (i.e., who clicked on the button "agree" after reading informed consent form) with no regard to sex, race, education, family status |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Conditionally healthy individuals expressing their interest to participate by clicking the link to the questionnaires and informed consent form that will be spreaded in social media, student communities, and university departmental staff communities
Key inclusion criteria (1 listed)
- consent to participate in the study, expressed by ticking the appropriate box on the website after reading the text of the informed consent, confirming their understanding of the study and their consent to participate in it;
Key exclusion criteria (1 listed)
- age < 18 years; This criterion is evaluated when completing the questionnaire, questionnaires from participants under 18 years old will not be included in the statistical analysis
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Online questionnairedata will be collected remotely on the online platform Qualtrics | Diagnostic test | study group |
Primary outcome
Prevalence of the phenomenon of epic dream disorder
Time frame: Through study completion, an average of 1 year
prevalence of the disease - the proportion of participants with the diagnosed epic dream disorder to the whole sample
62 secondary outcomes
Demographic outcomes: Sex
Time frame: Through study completion, an average of 1 year
Demographic outcomes: Age
Time frame: Through study completion, an average of 1 year
Demographic outcomes: Weight
Time frame: Through study completion, an average of 1 year
Demographic outcomes: Height
Time frame: Through study completion, an average of 1 year
Demographic outcomes: Level of education
Time frame: Through study completion, an average of 1 year
Demographic outcomes: name the University
Time frame: Through study completion, an average of 1 year
Demographic outcomes: name your department
Time frame: Through study completion, an average of 1 year
Demographic outcomes: year of study
Time frame: Through study completion, an average of 1 year
Demographic outcomes: Employment status
Time frame: Through study completion, an average of 1 year
use of nicotine
Time frame: Through study completion, an average of 1 year
use of alcohol
Time frame: Through study completion, an average of 1 year
Medical history
Time frame: Through study completion, an average of 1 year
duration of complaints
Time frame: Through study completion, an average of 1 year
Average duration of sleep
Time frame: Through study completion, an average of 1 year
dreams during daytime nap
Time frame: Through study completion, an average of 1 year
Amount of dreams during the night
Time frame: Through study completion, an average of 1 year
discomfort after the night of active dreaming
Time frame: Through study completion, an average of 1 year
triggers of active dreaming
Time frame: Through study completion, an average of 1 year
Intensity of thought activity in dream
Time frame: Through study completion, an average of 1 year
Intensity of speech activity in dream
Time frame: Through study completion, an average of 1 year
Intensity of running in dream
Time frame: Through study completion, an average of 1 year
Intensity of walking in dream
Time frame: Through study completion, an average of 1 year
Intensity of monotonous physical movements in dream
Time frame: Through study completion, an average of 1 year
Intensity of flight in dream
Time frame: Through study completion, an average of 1 year
Intensity of swimming in dream
Time frame: Through study completion, an average of 1 year
Intensity of jumping in dream
Time frame: Through study completion, an average of 1 year
Intensity of trip by transport in dream
Time frame: Through study completion, an average of 1 year
recalling dreams upon awakening
Time frame: Through study completion, an average of 1 year
characteristics of dream content
Time frame: Through study completion, an average of 1 year
characteristics of dream content
Time frame: Through study completion, an average of 1 year
Impression that your brain stays awake while you sleep
Time frame: Through study completion, an average of 1 year
Any peculiarities of your dream
Time frame: Through study completion, an average of 1 year
Awareness of a dream
Time frame: Through study completion, an average of 1 year
Subjective symptoms in the morning after a night of active dreaming
Time frame: Through study completion, an average of 1 year
Subjective symptoms in the morning after a night of active dreaming
Time frame: Through study completion, an average of 1 year
Subjective symptoms in the morning after a night of active dreaming
Time frame: Through study completion, an average of 1 year
Subjective symptoms in the morning after a night of active dreaming
Time frame: Through study completion, an average of 1 year
Subjective symptoms in the morning after a night of active dreaming
Time frame: Through study completion, an average of 1 year
Subjective symptoms in the morning after a night of active dreaming
Time frame: Through study completion, an average of 1 year
Subjective symptoms in the morning after a night of active dreaming
Time frame: Through study completion, an average of 1 year
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 24 May 2023.
- Individual participant dataSharing planned: Undecided
Related trials for Dream Disorder
Recruiting
Development & Validation of a Life Balance Program for Parents of Preschoolers: A Pilot Study
Parenting Stress, Mental Health
RecruitingObservational study
DREAM: Double Lung Transplant REgistry Aimed for Lung-limited Malignancies
Lung Cancer, Bilateral Cancer
RecruitingEarly Phase 1
Sleep, Dreaming, and Virtual Reality for Mental Health
Anxiety
RecruitingPhase 2
Induction of Dreaming With EEG and Anesthesia for Post-traumatic Stress Disorder
PTSD, Post-traumatic Stress Disorder
Not yet recruitingObservational study
A Multicenter Observational Study of Daridorexant in the Treatment of Insomnia
Insomnia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Mikhail Rumyantsev contact
Mikhail Poluektov, PhD study director
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Polina Pchelina, PhD principal investigator
I.M. Sechenov First Moscow State Medical University (Sechenov University)
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Dream Disorder, run by I.M. Sechenov First Moscow State Medical University at 1 site in Russia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 24 May 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Russia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Polina Pchelina, PhD (+79036701725, polbox@mail.ru, pchelina_p_v@staff.sechenov.ru), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Prevalence of the phenomenon of epic dream disorder (time frame: Through study completion, an average of 1 year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 May 2023.